Vanguard (NYSE: BCPC) reports zero beneficial ownership after realignment
Rhea-AI Filing Summary
The Vanguard Group reports it beneficially owns 0 shares (0%) of Balchem Corp common stock. The filing amends prior Schedule 13G filings to reflect an internal realignment effective January 12, 2026, under which certain Vanguard subsidiaries will report holdings separately.
This amendment states Vanguard holds no voting or dispositive power over Balchem common stock and that no single outside person is known to hold more than 5% of the class on Vanguard's behalf. The filing is signed by Ashley Grim on 03/26/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregated holdings after internal realignment; no Balchem shares reported.
The amendment confirms 0 shares beneficially owned and 0% voting or dispositive power in Balchem Corp as of the filing. It attributes the change to an internal realignment on January 12, 2026 and indicates certain subsidiaries will report separately in reliance on SEC Release No. 34-39538.
Cash‑flow treatment is not stated. Subsequent filings by Vanguard subsidiaries may show holdings if positions are held under different reporting entities.
FAQ
What does The Vanguard Group report for BCPC ownership?
Why does Vanguard show zero ownership in this Schedule 13G/A for BCPC?
Does this amendment indicate any single holder over 5% for BCPC on Vanguard's behalf?
Who signed the Schedule 13G/A amendment for Vanguard on BCPC?
Will Vanguard subsidiaries file separate reports for BCPC holdings?